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ADENOSINE V, 5 *-MONOPHOSPHATE SYSTEM 
IN ISLETS OP LANGERHANS
CHAPTER I
INTRODUCTION
Adenosine 3*» 5*-monophosphate (cyclic AMP), which 
is seen below (Pig. 1), was identified chemically by Suthezv 
land ̂  (1-3).
>
0 = ^
Pig. 1 - Adenosine 3't 5'-monophosphate.
The cellular levels of cyclic AMP are controlled
by adenylate cyclase, a membrane bound enzyme (4) which 
catalyzes its synthesis from adenosine triphosphate (ATP),
1
and phophodiesterase which mediates its degradation (5).
Since the discovery that cyclic AMP mediates its 
hyperglycemic effects by the stimulation of glycogen phos- 
phorylase, (1, 6, 7)> a great many regulatory functions 
of cyclic AMP in various tissue have been proved. A model 
of the protein component of membrane adenylate cyclase, 
which consists of at least two subunits, a regulatory sub­
unit (R) and a catalytic subunit (C), has been postulated 











Pig. 2 - Adenylate cyclase system.
In more detail, the regulator subunit is possibly
composed of several different parts. The adrenergic «1- 
receptor is in part connected to the catalytic subunit 
such that interaction with a catecholamine leads to a de­
crease in adenylate cyclase activity. In contrast, the 
adrenergic ̂ -receptor mediates an increase in the enzyme 
activity. However, receptors for other hormones could be 
located on the same or different subunits (9).
Many hormones, which themselves are the "first 
messengers" (illustrated on the following page), have been 
demonstrated to act on their target cells by utilizing 
cyclic AMP as a "second messenger", the intracellular sig­
nal, which may undergo amplification in different ways 
leading to the ultimate physiological responses (10).
Kuo and Greengard have proposed that all of the 
varied effects of cyclic AMP results from the phosphory­
lation of proteins with ATP by cyclic nucleotide depen­
dent protein kinases (11, 12). This hypothesis is supported 
by recent reports that some protein kinases have a greater 
affinity for cyclic AMP than cyclic GMP (13), and that 
histones (14), hormone-sensitive lipase from fat cells 
(15), microtubular protein from brain (16), glycogen phos- 
phorylase kinase from muscle (17, 18), as well as glycogen 
synthetase from muscle (19) are phosphorylated by cyclic 
AMP dependent protein kinase.
Panceatic insulin, a very important polypeptide 
hormone, serves to decrease hepatic intracellular cyclic 
AMP levels, while increasing such things as carbohydrate 
metabolism, glycogen storage, fatty acid synthesis, amino 
acid uptake, and protein synthesis. Insulin is known to be 
synthesized by and secreted from the ^-cells of raulticell-
ular pancreatic islets. Normally, islets only comprise 1-
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Fig. 3 - Second messenger concept.
lets in sufficient quantities for the study of their phy­
siological and biochemical properties has been elucidated 
(20). It is based on disruption of the acinar parenchyma 
by injecting buffer solution into the common bile duct. The 
gelatinous mass is cut into small pieces and incubated with 
crude collagenase. After complete digestion, islets are re­
leased, and islet-rich fractions can be separated from in­
cubation mixtures by sedimentation. The free, round (or 
ovoid), greyish-white and intact islets can be recognized 
easily under a dissecting microscope when viewed against a 
black background. Insulin is secreted in vitro from these 
isolated islets which appear normal by electron microscopy 
even after 1 , 5 hour incubation periods.
Various techniques used for the immunoassay of in­
sulin, and the study of the regulation of insulin secretion 
both in vivo and in vitro have been disscussed by Mayhew 
et al^(21). Metabolisable sugars, certain amino acids, en­
teric hormones, and sufonylureas may initiate insulin sec­
retion. The catecholamines, glucagon, adrenal corticoids, 
adrenocorticotropin, growth hormone, thyroid hormone, TSH, 
oxytocin, and vasopressin are known to be endocrine reg­
ulators of insulin secretion. However, "neurogenic" control 
of insulin secretion is another type of regulation.
Although an important role for cyclic AMP in in­
ouï in secretion has been suggested by recent studies, its 
actual meackanism remains obscure. The administration of
cyclic AMP enhances insulin secretion from perfused pan­
creas (22). Turtle et (23) have shown that in isolated 
islets, the changes in the levels of cyclic AMP correlate 
well with the pattern of insulin secretion in response to 
theophylline, epinephrine, adrenergic blocking agents, and 
glucagon. Many other hormones have been found to increase 
intracellular levels of cyclic AMP in other tissues. Of 
further interest, is the finding that many of the enzymes 
involved in glycolysis, the hexose monophosphate shunt, the 
Krehs cycle, and in glycogen synthesis are all in islet 
tissue (24-29). Cyclic AMP has been found to be involved 
in regulation of glycogen synthesis, glucose oxidation, 
gluconeogenesis and permeability in certain tissues (30). 
Several studies indicate that oxidative metabolism of glu­
cose and energy production is important for insulin secre­
tion (30, 32). Prom these observations, it can be conclu­
ded that the secretory mechanism of insulin is very com­
plicated and that under certain conditions, cyclic AMP may 
be involved.
In this study, the cyclic AMP system in islets of 
Langerhans includes adenylate cyclase, phosphodiesterase, 
cyclic AMP dependent kinase, and protein kinase modulator.
CHÀPT3R II 
MATERIALS AND METHODS 
Materials
A. Hormones
The sample of prostaglandins was the kind gift of 
Dr. J. 3. Pike, Upjohn. Leuteinizing hormone was obtained 
from Schwarz/Mann. Isoproterenol (L and DL form), Dl-epine­
phrine, L-norepinephrine, insulin (24 I.U./mg), ACTH (100 
I.U./mg), TSH (1 I.U./mg), pancreozymin, and secretin were 
purchased from Sigma.
B. Drugs
The following drugs were obtained from commercial
IIsources and include: KO 592 (1-5-methylphenoxy1-2-hydroxy 
3-isopropylpropranolamine), C. H. Boehringer and Sohn; phen- 
tolamine, Ciba Pharmaceuticals; MJ 1999 (sotalol). Mead 
Johnson; pilocarpine hydrochloride (4^ isoptocarpine), Alcon 
Laboratory; D-INPEA (N-isopropyl-p-nitrophenyl-ethanolaraine), 
Selvi e C., Italy; DL-propranolol, Sigma.
C. Enzymes and Amino Acids
The following materials were purchased from Sigma:
8
L-arginine, L-leucine, and pyruvate kinase. Collagenase 
(crude) was obtained from Worthington. Cyclic AMP dependent 
protein kinase from bovine heart was prepared by the pro­
cedure of Kuo ^  al. (12, 33).
p. Radioactive Chemicals 
The following radioactive chemicals were purchased
from commercial sources and include: ATP (0.33 Ci/
mole) and [2-^J adenine (25 Ci/mole), Schwarz/Mann; adeno-
sine-H^(G) 3*, 5*-cyclic phosphate (5 Ci/mole), New England
Nuclear. ATP was prepared by the procedure of Post
and Sen (34).
B. Others
AG-50WX8 (100-200 mesh, hydrogen form) was purchased 
from BioRad. Phosphoenolpyruvate and all non-radioactive 
nucleotides were obtained from Sigma. Other chemicals used 
were all reagent grade.
Buffers
Three kinds of buffer were employed in digestion 
or incubation. Hanks* solution (35), without glucose, con­






CaCl2*   140 .0 mg
MgOl2 .6H2O.....................100.0 mg
NaHCO^........................ 350 .0 mg
Krebs-Ringers bicarbonate buffer, saturated with 
95% Og- 5% OO2, v/v, contained per liter;




MgS0^.7HgO.....................3 2 0 .0 mg
CaClg 89.0 mg
glucose   2000.0 mg
The buffer used most often for collagenase diges­








Isolation of Pancreatic Islets 
(For Adenylate Cyclase Assay)
Three to seven male Sprague-Dawley rats (about 200 g
each) were used for each experiment. Bach rat was intra-
peri toneally injected with 0.3 ml of 4% pilocarpine just
10
three hours before surgery. The surgical procedure and 
cannulatlon of the common bile duct was similar to that 
of Lacy (20), except that 10 ml of Rodbell*s Tris-salts 
buffer, pH 7.4 (36), was injected into the pancreas instead 
of Hanks' solution (35). The pancreas was then removed, 
trimmed, chopped into small pieces, washed several times 
with the Tris-salts buffer and allowed to settle. Ten mg 
of collagenase for each pancreas was added to the sediment 
after removal of the supematent fluid and the mixture was 
stirred at 37® for 20 min.
Following this digestion, the mixture was poured 
onto a 180 mesh silk cloth and washed with 200 ml of cold 
Tris-HCL (40  mH) -MgSO^ (5 mM), pH 7 ,4 .  The cloth was then 
inverted and the islet-rich tissue washed into a tube with 
200-300 ml of the same solution. After several min the is­
lets had settled to the bottom of the tube and the super­
natant fluid was discarded. The islets were then trans­
ferred to a cold Petri dish and viewed with microscopic 
aid ( t o  x). Large islets were siphoned through an 18 gauge 
metal needle into a test tube or glass homogenizer. The 
islets were homogenized with four or five strokes of a 
tight fitting ground glass homogenizer, A Lowry protein 
assay (37) was performed for each experiment and the pro­
tein content estimated by comparison with bovine serum 
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Fig. 4 - Reactions involved in adenylate cyclase assay. 
The standard incubation mixture, in a final volume 
of 0.95 ml, consisted of the following: 40 mM Tris-HCl 
containing 5 mM HgSO^ (adjusted to pH 7.4 with 5 N NaOH); 
0.5 mM cyclic AMP; 1 mM /8-^c/ ATP (0.33 Ci/mole); 10 mM 
theophylline; 5 mM phosphoenolpyruvate; 9 I.H. of pyruvate 
kinase; 85 to 100 p.g islet protein; and test substances 
where indicated. This mixture was incubated at 30® for 
10 min. Unless otherwise stipulated, all experiments, in­
cluding the controls in which no islet homogenate was add­
ed, were performed by incubating the islet samples in Tri­
plicate for each type of treatment. Each Incubated sample 
was then separately assayed for the amount of radioactive 
cyclic AMP synthesized.
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The reactions were terminated by the addition of 
0,1 ml 50^ trichloracetic acid, followed by centrifugation 
and neutralization of the supernatant solution with 0.1 ml 
of 2.5 M Tris base. Next, 0.05 ml ZnSO^ (59̂ ) and 0.05 ml 
Ba(0H)2 (2.5656) were added to the supernatant solution and 
the mixture was centrifuged (5*000 x g, 10 min). The su­
pernatant fluid was then lyophilized overnight. The dried 
samples were dissolved in 0.5 ml water and applied to co­
lumns (0.5 X 2 .5 cm) of AG-50WX8 (Bio-Rad, hydrogen form, 
100-200 mesh). The columns were then eluted with water, 
and the third and fourth ml of eluate used as the cyclic 
AMP fraction. The optical density at 260 igu of this frac­
tion was monitored during the first 40 individual enzyme 
assays (Pigs. 7 and 8) and found to consisently reflect a 
cyclic AMP recovery of 75-80#. The recovery of cyclic AMP 
was also estimated to be 72-7856 when 1 nmole of adenosine- 
H^(G) 3*, 5'-cyclic phosphate (containing about 2 x lO^cpm) 
was added to the incubated islet samples immediately follow­
ing the addition of trichloracetic acid for the purpose of 
determining the recovery of the cyclic nucleotide. In all 
succeeding experiments the value of 75# recovery was used. 
The entire cyclic AMP fractions (2 ml each) were then mixed 
with 18 ml of Aquasol (New England Nuclear) and the radio­
activity was counted in a liquid scintillation spectrometer. 
In all cases, with 85 to 100 ;ig islet protein (representing 
50-60 islets) the control experiments produced about 2
13
nmoles of cyclic AMP per min per mg protein after subtrac­
tion of the negligible zero time control (0,1-0.2 nmole). 
This procedure for assaying adenylate cyclase activity is 
a modification of that developed by Krishna et (38), 
and was found to result in minimal contamination of the 
cyclic AMP fractions with the radioactive ATP. The authen­
ticity of cyclic AMP in the AG-50WX8 eluate was verified 
by the following experiment. The cyclic AMP sample obtained 
by the above procedure was chromatographed with standard 
cyclic AMP on a thin layer plate (SilicAR TLG-7GP, Mallin- 
ckrodt), using a solvent system consisting of isopropyl 
alcohol-HgO-Zg;^ NH^OH (7:3:1, v/v). The radioactivity re­
covered from the cyclic AÎ P spot on the developed plate 
represented the total radioactivity originally present in 
the cyclic AMP sample.
The results of all experiments are presented as the 
means and standard deviation for the triplicate samples of 
each set of treatments.
Prelabeling of Pancreatic Islets
Intact islets were used in this procedure. The 














Inhibitors of Cyclic 
AMP System of Islets
Radioactive 
Cyclic AMP
Pig. 5 - Reactions involved in prelabeling method.
Two methods were employed for prelabeling the is­
lets. The first method (Pigs. 10-12) consists of simultane­
ously digesting pancreatic pieces with crude collagenase 
and prelabeling the islets. Pancreatic pieces obtained 
from 2 male Sprague-Pawley rats (about 200 g each) were 
incubated, with stirring, at 37° in 2 ml of Rodbell's 
Tris-salts solution (36) in the presence of 20 mg of crude 
collagenase and 36 Ci of adenine for 30 minutes.
The digested tissue was then treated, and intact islets 
isolated, according to the procedures described previously. 
The collected islets were washed once with 30 ml of cold 
Ereb-Ringer bicarbonate buffer (previously saturated with 
93^ Og-S)̂  OOg,v/v, and containing no glucose), and were 
finally suspended in an appropriate volume of the same 
buffer to yield a suspension containing 30 -50 islets per
ml.
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The second method (Tables 8-11) consists of di­
gesting the pancreatic tissue followed by prelabeling the 
isolated islets from five rats. The procedures used to di­
gest pancreatic pieces and isolate islets were exactly the 
same as described before. About 2,000 islets were suspended 
in 4 ml of Krebs-Ringer bicarbonate buffer (previously sat­
urated with 95^ Og- 5^ OOg, v/v) containing 50 ;iGi of [2-^ 
adenine. The islets were incubated for 20min at 37®, with 
shaking, at the end of the prelabeling period, 30 ml of 
cold Krebs-Ringer buffer (containing no glucose) was added 
and the mixture was centrifuged at 2 ,0 0 0 r.p.m. for 3 min­
utes. The supernatant solution was then discarded. :The 
washing procedure was repeated 5 times, and the .islets were 
finally transferred to an appropriate volume of :same buffer 
to yield a suspension containing 20 -4 0 islets per ml.
In experiments (Table 12) in which the absolute 
levels of total cyclic AMP were measured by the protein 
kinase catalytic method (33), the islets were isolated as 
in the second method, with the omission of the prelabeling 
step. The islets were suspended in an appropriate volume 
of Krebs-Ringer bicarbonate buffer to yield a suspension 
containing 45 islets per ml.
Incubation of Islets and Measurement of Cvclic AMP levels
In experiments (Pigs. 10-12; Tables 8-11) in which 
the relative levels of radioactive cyclic AMP.ln:iSlet
16
cells were measured, appropriate volumes of the islet sus­
pension were incubated at 57° for different periods in the 
presence of various agents, as indicated in the legends to 
the figures and the tables. At the end of the incubation 
period, one-tenth volume of 50^ trichloracetic acid was 
added to the incubation mixture followed by the addition 
of 0.02 ml of 1 ;iU cyclic AMP as a carrier. The islet sus­
pension was then sonicated for 0 .5  min, then centrifuged 
at 2,000 r.p.m. for 5 min. The precipitate was removed and 
the supernatant fluid was then neutralized with 1 M Tris. 
The radioactive cyclic AMP in the supernatant fluid was 
purified by the same procedure described in the adenylate 
cyclase assay. One ml of the pooled cyclic AMP fraction 
was assayed for radioactivity.
The absolute amounts of cyclic AMP (Table 12) were 
measured by cyclic AMP dependent protein kinase catalytic 
method (55). The experimental procedure was based on the 








Pig. 6 - Reaction involved in cyclic AMP dependent 
protein kinase catalytic method .
The incubation mixture used for the assay contained, 
in a final volume of 0.2 ml; sodium acetate buffer, pH 6.0,
17
10 /imoles; magnesium acetate, 2 jimoles; histone mixture,
40 ̂ g; ATP, 1 nmole, containing about 2.1 x lO^cpm;
heart protein kinase, 3 Incubations were carried out 
at 30® for 5 min in a shaking water bath. The reaction was 
terminated by addition of 2 ml of 5^ trichloracetic acid 
containing 0.255̂  sodium tungstate, pH 2.0 (39); 0.1 ml of
0 .63^ bovine serum albumin was added as a carrier protein. 
After standing at 0® for 5 min, the mixture was centrifuged, 
and the supernatant solution removed by aspiration. The 
precipitate was dissolved in 0.1 ml of 0.5 H NaOH, and 2 
ml of 5^ trichloracetic acid-0 .255  ̂sodium tungstate solu­
tion, pH 2,0, was added. This mixture was centrifuged fol­
lowed by aspiration of the supernatant described before.
The above procedure was repeated once more. The protein was 
finally collected by centrifugation and dissolved in 0 .1 ml 
of 0.5 N NaOH, and the radioactivity was measured in a liq­
uid scintillation counter. The amount of cyclic AMP present 
in the samples was determined from standard curves with 




Isolation of Pancreatic Islets 
The effects of pilocarpine usage on the yield of 
large islets as compared to other procedures, are presented 
in Table 1• In author's hands, treatment of rats with pilo­
carpine facilitated more than a 10-fold increase in the 
yield of pancreatic islets, i.e. from 25 -35 islets per pan­
creas from the untreated rats to 350-500 islets from the 
treated rats. When the amount of collagenase used was in­
creased 6-fold and the volume of the digestion mixture was 
increased 4- to 8-fold by the addition of Hanks* solution, 
the yield of islets was less than one-half of our usual 
value. The procedure described here,to the authors knowledge 
yields the greatest amount of islets per pancreas, and more­
over, the islets isolated have been shown to possess adeny­
late cyclase responsive to various agents which are known to 
stimulate insulin secretion.
Another method to isolate islets by discontinous 
dextran density gradients (2.5^# 12#, and 22#; 2.5#, 8#,
14#, 16#, 18.5#, and 22#. at lOOOxg centrifugation for 10
TABLE 1
THE EFFECT OF PILOCARPINE PRETREATMENT ON THE YIELD OF ISLET ISOLATED
FROM RAT PANCREAS









min mg/ml number of
islets/pancreas
None 4 ml Hanks' solution 15 60 80-150
None 4 ml Rodbell's Tris-
salts solution 15 60 80-150
None None 20 10 25-55
Pilocarpine None 20 10 350-500
\o
Method for isolation of pancreatic islets was as described under 
"Experimental Procedure" except for some modifications as indicated in 
the table.
20
minute) was also tried. Although islets could he isolated 
between the 12^ and 22^ density layers (or between the 
1656 and 18.5^ density layers), the total yield of islets 
was quite poor. Unfortunately, islets could not be frozen 
and stored to accumulate large quantities for study. Only 
most of phosphodiesterase activity was found to be stable, 
while adenylate cyclase activity was rapidly lost (data 
not shown).
Adenylate Cyclase Activity In 
Isolated Pancreatic Islets
A. Dependence of Cyclic AMP Production on Incubation 
Time and Islet Protein Concentration 
Pig. 7 illustrates the time course of the reaction 
at five and ten minutes in the presence and absence of the 
polypeptide enteric hormone, secretin. The control réponse 
is roughly linear with time while the stimulated enzyme 
further increases Its activity in the second 5 min. period,
i.e., a 49^ stimulation at 3 min. and 130^ at 10 min.
The dependence of cyclic AMP production upon islet 
protein concentration is demonstrated in Pig. 8 . A linear 
relationship was noted both in the presence and absence of 
secretin. Similar linearity was also observed with experi­
ments in which the adenylate cyclase preparation was in­
cubated with glucagon and ACTH (data not shown).
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Pig. 7. The dependency of cyclic AMP production 
upon incubation time. The assays were performed under 
standard conditions with 0 .1 0 2 mg protein/ml, in the 





Pig, 7 - The dependency of cyclic AHP-production 
upon incubation time.
23
Pig. 8 • The dos e-dependency of cyclic AMP pro­
duction as a function of the amount of adenylate cyclase. 
The assays were performed under the standard conditions 
except for the variation of enzyme amount, in the absence 
(•) and presence (o) of secretin (20 ;ig/ml). Each point 









Pig. 8 - The dose-dependency of cyclic AMP pro­
duction as a function of the amount of adenylate cyclase.
25
B. The Effect of Polypeptide Hormones
The main purpose of the present study was to ascer­
tain the relationship between the activation of islet 
adenylate cyclase and the stimulation of insulin secretion. 
Glucagon, previously found to stimulate insulin secretion 
in isolated islets (40) and other pancreatic tissue pre­
parations (41» 42)» stimulated islet adenylate cyclase. 
Maximal stimulation of islet adenylate cyclase was found 
to occur at about 30 pU glucagon (Fig. 9) compared with 2 
>xM for adenylate cyclase of adipocytes (43) and 0.1 jaM for 
that of liver cells (44). Turtle and Kipnis (23)» using 
intact rat islets» have reported that glucagon» in the 
presence of theophylline» causes an increase in islet cy­
clic AMP content. Their results are consistent with our 
observations» although the intact cells are apparently 
more sensitive to hormone than is the adenylate cyclase 
of islet homogenates.
In view of the recently published observations by 
Rodbell et (45) that guano sine phosphates augment the 
effect of glucagon in stimulating liver cell adenylate 
cyclase. We studied the effects of GTP and GDP on the islet 
enzyme. While glucagon alone (1 jxM) had virtually no effect 
on enzyme activity and 5 /iM GDP alone gave a 511  ̂stimula­
tion» the combination of the two agents resulted in a 118)G 
stimulation (Table 2). A ten fold increase In GDP concen­
tration (50 jLiii) resulted in a 146^ stimulation of adeny-
26
Fig. 9. The effect of glucagon upon islet adenylate 
cyclase activity. The assays were performed under standard 
condition at the indicated glucagon concentrations. The 
basal level of activity (with no added glucagon), which 
amounts to 2.3 nmoles cyclic AîiP produced per min per rag 
islet protein, was normalized to 100. Each point shown 
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Fig. 9 -The effect of glucagon upon islet adenylate 
cyclase activity.
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Table 2. Effects of glucagon, GDP, GTP, and EGTA, 
present singly or in combination on the islet adenylate 
cyclase activity. The incubation conditions were as des­
cribed under "Experimental Procedure". The control (with­
out added agent) value, represents 2 .0 1 - 0 .0 5 nmoles cy­
clic AMP per min per mg islet protein. Each value shown 
represents mean - standard deviation of triplicate samples,
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TABLE 2
EFFECTS OP GLUCAGON, GDP, GTP, AND EGTA, PRE­
SENT SINGLY OR IN COMBINATION ON THE 
ISLET ADENYLATE CYCLASE ACTIVITY
Addition and concentration Relative cyclic
AMP production
None (control)    .....100.0 i 2.5
Glucagon (5.0 /im)  *129.2 ± 4 .3
EGTA (1 .0 mM)............................. 1 2 1 .0 ± 4 .6
Glucagon (5.0 ;iM)
+ EGTA (1.0 mM)  2 5 1 .9 ± 8.2
Glucagon (1 /iM)   100,0 ±2,1
GDP (5 ̂ M)................................ 1 5 1 .2 ± 4 .2
Glucagon (1  218.5 ± 8.9
+ GDP (5 m )
GDP (50 }M)...............................246.8 ± 6.7
GTP (5 jaM)................................218.9 ±16.6
T ' ....................................
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late cyclase activity in the absence of glucagon. GTP, at 
a concentration of 5 stimulated the enzyme activity 
II99G, whereas in the presence of 1 /iM glucagon, the sti­
mulation was reduced to 8I96. Rodbell et (45, 46) found 
that in liver the glucagon-stimulated adenylate cyclase 
activity is further augmented by both GDP and GTP under 
their experimental conditions.
At a concentration of 1 mM, the calcium chelating 
agent EGTA stimulated the basal activity of islet adenylate 
cyclase by 21^. It was found to synergistically enhance 
the stimulatory effects of 5 ̂  glucagon from 20)6 in its 
absence to 152)6 in its presence (Table 2). Similar results 
have been obtained by Hepp al. (47) with liver adeny­
late cyclase. They postulated that the EGTA stimulation is 
due to the chelation of inhibitory membrane-bound calcium 
ions.
Other polypeptide hormones were also tested for 
their effects on islet adenylate cyclase (Table 3). The 
two gut hormones, secretin (also see Figs. 7 and 8) and 
pancreozymin, were both found to be effective stimulants. 
These hormones have been reported to stimulate insulin 
release from pieces of rabbit pancreas (48, 49), but are 
ineffective in stimulating insulin release from isolated 
rat islets (50) and other pancreatic tissue preparations 
(51, 52). Neither of the hormone preparation used in the
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experiments was pure; the secretin (Sigma, Type I) contain­
ing 25-30 units of pancreozymin per 100 units of secretin, 
and the pancreozymin (Sigma, GradeX)» containing about 
10^ secretin. The results obtained with the two hormone 
preparations could be due to the action of either one of 
them, or of both. Further elucidation of this point re­
quires the use of pure hormone preparations.
ACTH activated islet adenylate cyclase to a greater 
extent than did any other hormone (Table 3). This hormone 
has been found to enhance insulin secretion from isolated 
rat pancreas (22, 42) and increase plasma insulin levels 
in mice (53). TSH, previously shown to augment the glucose 
-induced insulin secretion from pieces of rat pancreas 
(42), was also found to activate islet adenylate cyclase. 
Somatotropin also increased the activity of islet adeny­
late cyclase. This hormone has been found to elevate canine 
serum levels of insulin ̂  vivo (54), but has not been 
shown to increase insulin secretion ̂  vitro (31, 55). 
Luteinizing hormone was not active at the concentration 
tested. Insulin at 20 per ml significantly inhibited 
islet adenylate cyclase, suggesting that insulin may reg­
ulate the islet cyclic AMP levels (and thus insulin secre­
tion from the organelles) through a feed-back control me­
chanism.
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Table 3. Effects of polypeptide hormones on islet 
adenylate cyclase activity. Experimental conditions were 
as under "Experimental Procedure". The control (without 
added agent) value, represents 2.35 ±0.11 nmoles cyclic 
AMP produced per min per mg islet protein. Each value shown 
represents mean ± standard deviation of triplicate sample, 
except that the value obtained with luteinizing hormone 
was from a simple sample.
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TABLE 3
EFFECTS OF POLYPEPTIDE HORMONES ON ISLET 
ADENYLATE CYCLASE ACTIVITY
Additions and concentrations Relative cyclic AMP
production
None (control)........................ lOO.Oi 4.7
ACTH (46 I.D./ml)..................... 361.3±23.2
ACTH (23 I.U./ral)..................... 508.9±16.3
Somatotropin (100 jtiM)................. ..181.8± 6.6
Somatotropin (30 jiN).    .............. 224.3-14.3
TSH (20 )ig/ml)....................   204.2±14.9
Pancreozymin (20 >ig/ml)................186.7i 4.7
Luteinizing Hormone (20 >ig/ml) ..... .101.2
Insulin (20 jig/ml)...................... 74.8± 6.1
Insulin UOjag/ml).... 87.7- 8.2
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C, Effects of Amino Acids, Alcohol,
Acetylcholine and NaP
Several amino acids have been found to stimulate 
insulin release from pieces of rabbit pancreas. Milner 
(56) has shown, for example, that arginine enhances glu­
cose-induced insulin secretion and that leucine,, even in 
the absence of glucose, causes insulin release. Theophyl­
line was found to enhance leucine-induced but not arginine 
-induced secretion. In the present study, neither of these 
amino acids were found to stimulate islet adenylate cy­
clase (Table 4). lu fact, they slightly inhibited enzyme 
activity, suggesting that cyclic AMP may not mediate their 
insulinogenic effect.
Ethanol was found to stimulate islet adenylate 
cyclase (Table 4). The lowest level tested (0.05̂ 6 or 8.6 
mM) was found to give a 59)G stimulation, whereas the sti­
mulation was reduced at higher ethanol concentrations. 
Various alcohols have been found to stimulate adenylate 
cyclase of both rat liver and hamster insulinoma (insulin 
producing islet adenoma) (57). Ethanol, for example, was 
found to stimulate the hepatic enzyme but was not tested 
with the insulinoma. 2-Propanol, which stimulated insu­
linoma adenylate cyclase, also enhanced the glucagon 
response of this enzyme. Clinical observations have in­
dicated that ethanol administration (oral or intravenous) 
results in an increase in the plasma insulin response to
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Table 4. • Effects of leucine, ethanol and acetyl­
choline on islet adenylate cyclase activity. The incubation 
conditions were as described under "Experimental Procedure". 
The control (without added agent) value, represents 1.88 ± 
0 .0 7 nmoles cyclic AMP produced per min per mg islet pro­




EFFECTS OP LEUCINE, ETHANOL AND 
ACETYLCHOLINE ON ISLET ADENY­
LATE CYCLASE ACTIVITY
Addition and concentration Relative cyclic
AMP production
None (control)     100.0 ± 3.7
L-leucine (5.0 mM)   73.1 ±3.3
L»leucine (2.5 mM)......................... 80.5 ± 3.6
L-arginine (5.0 mM)   50.8 ± 3.2
L-arginine (2.5 mM) .......64.7 ±1.9
Ethanol, 0.5% (v/v)........................105.9 ± 2.9
Ethanol, 0.1% (v/v)........................128.7 ± 5.1
Ethanol, 0.05% (v/v).......................159.5 ± 2.6
Acetylcholine (0.1 mM).................... 279.1 ±12.3
NaP (10.0 mM).............................405.5 ±28.7
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glucose. Ethanol alone, however, did not cause an elevation 
of plasma Insulin levels (58, 59). Thus, ethanol stimula­
tion of islet adenylate cyclase may enhance glucose-initi­
ated insulin secretion. -
Cholinergic drugs have been found to stimulate the 
release of insulin from slices of rat pancreas (60, 61). 
Acetylcholine has been shown to stimulate the release of 
insulin from isolated rat islets in the presence of sub- 
optimal glucose levels (1.5 rag/ml) (40). The finding (Table
4) that acetylcholine stimulates islet adenylate cyclase
is consistent with these observations. To the author's knowl­
edge, adenylate cyclase stimulation by acetylcholine has not 
been found with other tissues. Sodium fluoride greatly 
stimulated islet adenylate cyclase (Table 4), as noted 
with many other tissue preparations.
D. Effects of Glucose and Hypoglycemic Drugs 
Glucose was found to have a slight inhibitory
effect upon islet adenylate cyclase at 0.5-5.0 mU (Table
5), concentrations known to initiate insulin secretion 
(44), The data from the present study are similar to those 
reported by Atkins cmd Matty with mouse islets (62). These 
results are consistent with an Intracellular mechanism of 
secretory stimulation by this metabolite, especially since 
glucose freely permeates islet cells (63, 64).
Tolbutamide, 1-butyl-3-(p-tolylsulfonyl) urea, a
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Table 5 Effects of glucose and hypoglycemic drugs 
on islet adenylate cyclase activity. Experimental conditions 
were as described under "Experimental Procedure". The con­
trol (without added agent) value, represents 2.26 - 0.06 
nmoles cyclic AMP produced per min per mg islet protein.




SPPECTS OP GIUOOSE AND HYPOGLYCEMIC DRUGS 
ON ISLET ADENYLATE CYCLASE ACTIVITY
Addition and concentration CmM) Relative cyclic
AMP production
None (control)....................... 100.0 ± 2.7
D-glucose (5.0 mU)   «94.5 ^ 2.4
D-glucose (1.0 mM)....................97.8 ± 2.7
D-glucose (0.5 mM).....................100.1 ± 2.5
Tolbutamide (0.5 mM).................275.7 ±20.1
Tolbutamide (0.1 mM)........... 234.6 ±26.2
Phenformin (0.1 mM)..................105.6 ± 2.5
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common clinically utilized drug for the treatment of dia­
betes, was found to effectively stimulate islet adenylate 
cyclase; 0.1 and 0.3 mil concentrations of the hypuglycemic 
drug gave 135 and 174^ stimulation, respectively (Table 5 ). 
This drug has been found to stimulate insulin secretion 
both to vitro with isolated rat islets (63) and to vivo 
(66, 67). Levey et al. have recently reported that tolbu­
tamide stimulates adenylate cyclase of rabbit heart (68) 
and islet cell adenoma (69). Tolbutamide has also been 
shown to inhibit phosphodiesterase activity in an insulin- 
secreting islet cell tumor of Syrian golden hamster (70) 
and increase cyclic AMP level to fat cells (71). However, 
Heilman et al. (72) have presented evidence that tolbu­
tamide does not enter the ̂ -cells and therefore must have 
an extracellular site of action.
Another hypoglycemic drug, phenformin (1-phen- 
ethylbiguanidine), thought to act intracellularly and 
differently from tolbutamide (73), had no effect on islet 
adenylate cyclase (Table 5).
£. Effects of Prostaglandins and Adrenergic Agents
Prostaglandins E^, gg, A^, and P-,̂ , each tested 
at a concentration of 20 ;ig/ml, significantly enhanced 
the production of cyclic AMP (Table 6). In vivo insulin 
secretion is induced by the prostaglandins (74), although 
prostaglandin Ê  (1 ;»g/ml), in the presence of 1.3 mg/ml
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glucose, fails to stimulate the secretion of insulin by 
isolated rat islets (40).
Atkins and Matty (62) have presented evidence that 
epinephrine and isoproterenol, in the presence of phento- 
lamine (anot-adrenergic blocker), increase adenylate cy­
clase activity of microdissected mouse islet tissue. They 
reported that the stimulation by epinephrine in the pre­
sence of -blocker is inhibited by propranolol (a ̂ -adren­
ergic blocker). They suggested that stimulation of islet 
adenylate cyclase is a ̂ -adrenergic function while inhi­
bition of the cyclase activity is an ol-adrenergic function.
Montague and Cook (44) have reported that epine­
phrine inhibits glucose-induced insulin secretion and 
lowered the intracellular cyclic ATflP content of isolated 
islets. Epinephrine and norepinephrine were also shown to 
inhibit insulin secretion ̂  vitro with a hamster pancreas 
preparation (75). Turtle and Kipnis (23) have observed 
that epinephrine plus phentolamine, but not epinephrine 
plus propranolol, increses of cyclic AMP levels in intact 
islets.
In the present studies with rat islet adenylate 
cyclase, epinephrine and norepinephrine were both found 
to inhibit its activity by about 14-17^; this inhibition 
was increased to about 35-37)6 in the presence of KÔ 592, 
a ̂ -adrenergic blocking agent (Table 6). Conversely, both 
catecholamines, in the presence of phentolamine, activated
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Table 6. Effects of epinephrine, norepinephrine.
Itisoproterenol, KO 592, phentolamine, and prostaglandins, 
present singly or in combination on islet adenylate cy­
clase activity. Experimental conditions were as described 
under "Experimental Procedure", The control (without add­
ed agent) value, represents 2,14 - 0,04 nmoles cyclic AifP 
synthesized per min per mg islet protein. Each value shown, 




SPPECTS OP EPINEPHRINE, NOREPINEPHRINE, ISOPROTERENOL, 
KÔ 592, PHENTOLAMINE, AND PROSTAGLANDINS ON 
ISLET ADENYLATE CYCLASE ACTIVITY
Addition and concentration Relative cyclic 
AMP production
None (control)................. ± 1.9
DL-epinephrine (0.1 mM)....... ± 3.6
DL-epinephrine (0.1 mM)
+ KO 592 (0.1 mM) ....... i 8.0
DL-epinephrine (0.1 mM)
+ phentolamine (0.1 mM) ...... ±19.8
L-norepinephrine (0.1 mM)...... ± 4.8
L-norepinephrine (0.1 mM)
+ KO 592 (0.1 mM) ...... ± 6.7
L-norepinephrine (0.1 mM)
+ phentolamine (0.1 mM)....... ±11.5
L-isoproterenol (0.1 mM)....... ±27.7
L-isoproterenol (0.1 mM)
+ KG 592 (0.1 mM) ....... ±25.0
PG E-, (20 /ig/ml)............... ±32.7
PG Eg (20 ;ig/ml)............... ±18.5
PG A-i (20 jag/ml)............... ±16.8
PS P w  (20 w/ml).............. ±28.4
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adenylate cyclase by about 300^. Isoproterenol alone great­
ly activated the enzyme and this activation was largely
Ifabolished by KO 592, indicating that the activation by 
isoproterenol was characteristically a jg-effect.
P. Effects of 3*, 5'-Cyclic Nucleotides 
Cyclic AMP, cyclic UMP, and cyclic IMP were found 
to have inhibitory effects on islet adenylate cyclase at 
concentrations higher than 2 mM. Cyclic GMP, even when 
tested at a concentration of 0.1 mM, tremendously inhibited 
adenylate cyclase activity. It could be due to the inhibi­
tion of ATP binding. However, both cyclic IMP and cyclic 
CMP did not significantly inhibit the production of cyclic 
AMP (Table 7).
Regulation of Cyclic AMP Levels in 
Intact Pancreatic Islets
Glucagon, isoproterenol, ACTH, and acet]gcholine, 
agents known to stimulate insulin release^all increased 
the accumulation of radioactive cyclic AMP in intact rat 
pancreatic islets incubated in the presence of 10 mM theo­
phylline (Pig. 10). The accumulation of cyclic AMP in all 
cases was reasonably proportional to the incubation time.
It has been shown that these hormones also stimulated 
adenylate cyclase in islet homogenates. The cyclic AMP 
level for the control experiment (in which no stimulatory
45
Table 7. Effects of 3*# 5'-cyclic nucleotides on 
islet adenylate cyclase activity. Experimental conditions 
were as described under "Experimental Procedure". The con­
trol (without added agent) value, represents 1.88 - 0.99 
nmoles cyclic AMP synthesized per min per mg islet protein. 




EFFECTS OP 3% 5’-CYCLIC NUCLEOTIDES ON 
ISLET ADENYLATE CYCLASE ACTIVITY
Addition and concentration Relative cyclic
AMP production
None (control) 100.0 ± 4.5
Cyclic AMP (2 mM).......................86.6 ± 2.7
Cyclic AMP (5 mM).......................67.7 ± 3.1
Cyclic GMP (0.1 mM) 0.0 t 2.5
Cyclic UMP (2 mM).......................75.8 ± 3.4
Cyclic IMP (2 mM).......................71.4 i 9.5
Cyclic IMP (3 mM).......................57.9 ±11.0
Cyclic TMP (2 mM)...................... 102.8 ±14.0
Cyclic TMP (3 mM) 92.8 ± 6.4
Cyclic CMP (3 mM) 100.6 ± 5.8
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Fig, 10, Stimulation by some hormones of radioactive 
cyclic AMP accumulation in rat pancreatic islets as a func­
tion of incubation time in the presence of a high concen­
tration of theophylline. About 20 islets were incubated for 
varying time intervals in 0,5 ml of Krebs-Ringer bicarbonate 
buffer containing 10 raM theophylline. The radioactive cyclic 
AMP found in the zero time sample was about 3200 cpm per mg 
protein. X, control; a , glucagon (0.1 mM); # , DL-isopro- 
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radioactive cyclic AMP accumulation In rat pan­
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agents were added) at the end of the 10-min Incuhation was 
higher than the zero-time value. Wxxh similar experiments 
in which the islets were incubated in the presence of 3 mM 
theophylline, the levels of cyclic AMP found in the control 
and the hormone-treated islet samples were considerably 
lower than the zero-time value (Pig. 11), suggesting an 
extremely high phosphodiesterase activity in rat islets.
In order to insure a positive increment in the cyclic AMP 
level during the incubations. The islets were incubated 
with 10 mM theophylline in all experiments.
The dose-dependent stimulation by glucagon, acetyl­
choline, isoproterenol and ACTH of cyclic AMP accumulation 
in the islets is illustrated in Pig. 12. EOTA, which slight­
ly increased the cyclic AMP level when present alone, acted 
synergistically with glucagon to greatly increase the cy­
clic AMP levels, confirming these observations of their 
synergistic effect on adenylate cyclase activity of islets.
The effects of some other agents on the islet cy­
clic AMP levels are presented in Table 8. Secretin and 
prostaglandins (Ê , Eg» A^ and P^^), which have been re­
ported to have an insulin-releasing action (48, 49» 74)» 
were all capable of elevating cellular cyclic AMP levels. 
Thyroid-stimulating hormone, with an unclear insulinogenlc 
effect, was also active. It is interesting that tolbuta­
mide, an oral hypoglycemic drug, caused an elevation of 
cyclic AMP in islets. The level of islet cyclic AMP was
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Pig, 11. Stimulation by some hormones of radioactive 
cyclic AMP accumulation in rat pancreatic islets as a func­
tion of incubation time in the presence of a low concen­
tration of theophylline. About 20 islets were incubated for 
varying time intervals in 0,5 ml of Kreb-Ringer bicarbonate 
buffer containing 3 mM theophylline. The radioactive cyclic 
AîfiP found in zero time sample was about 3200 cpm per mg 
protein, X, control; □ , glucagon (0,1 mM); # , DL-isopro- 
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Fig. 11 - Stimulation by some hormones of radio­
active cyclic AMP accumulation in rat pancreatic is­
lets as a function of incubation time.
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Pig.l2. Stimulation ty some hormones of radioactive
cyclic AMP accumulation in rat pancreatic islets as a fun­
ction of hormone concentration. About 20 islets were incu­
bated, in the presence of varying the concentration of 
hormones, for 10 rain in 0.5 ml of Krebs-Ringer bicarbonate 
buffer containing 10 mî4 theophylline. The basal value Cfound 
in the absence of added hormones) of radioactive cyclic AMP
at the end of 10 min incubation was about 3000 cpm per mg 
protein. O, glucagon; #, glucagon + EGTA (2 mM) ;®,DL-iso- 
proterenol; o , corticotropin; X, acetylcholine.
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Fig, 12 - Stimulation by some hormones of radio­
active cyclic AMP accumulation in rat pancreatic islets 
as a function of hormone concentration.
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Table 8 • Effects of prostaglandins, secretin, 
thyroid-stimulating hormone, tolbutamide, leucine and 
glucose on cyclic AMP levels in pancreatic islets• About 
70 islets were incubated in 2.5 ml of Krebs-Ringer bi­
carbonate buffer containing 10 mM theophylline and vari­
ous additives, at 37® for 10 min, with shaking. Each incu­
bation was performed at least in duplicate and the mean 
and the individual value (in parentheses) are presented.
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TABLE 8
SPPBCTS OP PROSTAGLANDINS, SECRETIN, TSH, TOLBUTAMIDE, LEU­
CINE AND GLUCOSE ON CYCLIC AMP LEVELS IN PANCREATIC ISLETS
Additive Cyclic AMP found
cpm X 10 /mg protein
None (control)............. (22.0 20.5)
Prostaglandin E-j (10 ̂ g/ml). • • 61 • 9 (57.7 66.0)
(20 jag/ml). .. 72.0 (66.2 78.0;81.8;61.8)
(30^g/ml). . . 79.9 (85.0 74.8)
Prostaglandin E2 (20 Mg/ml). 26.5 (23.4 29.6)
(3 0 jag/ml). .. 81.0 (77.1 84.9)
Prostaglandin Af (20 )ig/ml). - . 49.3 (38.3 60.3)
(3 0 jmg/ml). . . 62.4 (70.1 54.7)
Prostaglandin P̂ gt (20 ng/ml) . .96.3 (86.3 106.2)
(30 >ig/ml) . . 4 6.8 (44.3 49.2)
Secretin (20 ̂ g/ml)....... (40.7 44.2)
TSH (20 ;%g/ml)............ (32.2 39.6)
Tolbutamide (0.1 mM)...... (27.5 49.3;40.2;33.0)
Leucine (5 mM).......... (22.6 2 4.3)
Glucose (5 mM)............ (22.1 20.8)
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not significantly increased ty leucine or glucose, suggest­
ing that the action of these metabolites to stimulate in­
sulin secretion may not be mediated through a mechanism 
involving cyclic AMP. The effects of these agents on islet 
cyclic AMP levels confirmed the findings previously made 
with adenylate cyclase in the islet homogenates.
It has been shown (23, 62) that rat pancreatic is­
lets contain both o(-and ̂ -adrenergic receptors. Interac­
tion of agents with the of-receptor causes a reduction in 
adenylate cyclase activity and consequently a decrease in 
cellular cyclic AMP. Interaction of agents with the ̂ -re­
ceptor, on the other hand, results in an activation of 
adenylate cyclase and an increase in cyclic AMP levels.
The effect of isoproterenol in increasing islet cyclic AMP 
level was effectively antagonized by all four of the fi- 
adrenergic blockers (propranolol, MJ 1999» KO 592, and D- 
INPEA) tested (Table 9). It is clear that activation of 
adenylate cyclase and the consequent stimulation of insulin 
secretion (76) by isoproterenol is a typical ̂  -adrenergic 
effect. Epinephrine and norepinephrine caused reductions 
in islet cyclic AMP levels (Table 10), in agreement with 
the known effect of these hormones in inhibiting insulin 
release (31, 44). In the presence of o(-adrenergic blocking 
agents, such as phenoxybenzamine and phentolamine, the in­
hibition by these two hormones was overcome, and pronounced 
increases in cyclic AMP due to these hormones were ulti-
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Table 9. Inhibition by ̂ -adrenergic blocking agents 
of increase in islet cyclic AMP, About 90 islets were incu­
bated in 2.5 ml of Krebs-Ringer buffer containing 10 mM 
theophylline and various additives at 37®, with shaking, 
for 10 min. Each incubation was performed in duplicate and 




INHIBITION BY ̂ ADRENERGIC BLOCKING AGENTS 
OP INCREASE IN ISLET CYCLIC AMP
Additive Cyclic AMP found Effect of 
agent
cpm X 10^/mg protein 9É control
None
(control)....... ..19.5 (20.6; 18.9) 100
DL-Isoproterenol 












(0.1 mM)......... ..19.8 (21.5; 18.1) 102
DL-Isoproterenol 
(0.2 raM)
+ D-INPEA (0.4 mM).108.7 (83.9; 133.4) 557
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Table 10. Comparison of effect of epinephrine and 
norepinephrine on islet cyclic AMP levels in the absence 
and presence of ««.-adrenergic blocking agents. About 65 
islets were incubated in 2.5 ml Krebs-Ringer bicarbonate 
buffer containing 10 mM theophylline. Each incubation was 
performed in duplicate and the mean and the individual va­
lues (in parentheses) are presented.
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TABLB 10
COMPARISON OP EPPEGT OP EPINEPHRINE AND NOREPINEPHRINE ON 
ISLET CYCLIC AMP LEVELS IN THE ABSENCE AND PRESENCE 
OP ot-ADRENERGIC BLOCKING AGENTS
Additive Cyclic AMP found
cpm X 10'Vmg protein
None (control) ....... . . . . (19.0;21.2)
DL-Epinephrine (0.05 mM)....... (3.4;0.4)
DL-Eplnephrlne (0.05 mM)
+ Phenoxytenxamine (0.03 mM).. (79.8;99.9)
DL-Eplnephrlne 10.05 mM)
+ Phentolamine (0.04 mM)..... (82.2;92.4)
L-Noreplnephrlne (0.05 mM)...... (8.0;2.5)
L-Noreplnephrine (0.05 mM)
+ Phenoxyhenzamlne (0.03 raM).. (30.7:23.0)
L-Noreplnephrlne (0.05 mM)
+ Phentolamine (0.04 ran)..... (87.5:115.5)
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mately noted. It seems that the action of epinephrine and 
norepinephrine in the absence of phenoxyhenzamlne and phen­
tolamine is predominantly an >Uadrenergic effect, while 
the action of these hormones becomes a typically ̂ -adren­
ergic one in the presence of the ^-adrenergic blockers.
The results obtained with the present study employing in­
tact islets confirmed both the findings of Turtle and Kip­
nis (23) with intact islets, and the studies of islet adeny­
late cyclase.
It has been shown that GTP enhances glucagon-sti­
mulated adenylate cyclase activity in rat liver plasma m&ù- 
brane preparations (43) and rat islet homogenates, and that 
GTP itself also stimulates the enzyme activity in these two 
systems (45). In the present study with intact islet cells, 
GTP was found to cause increases in islet cyclic AMP lev­
els; the stimulation seen with 10 joM GTP being much higher 
than that seen with 5 GTP (Table 11). The stimulatory 
effect of 5 jhM GTP and 5 >iM glucagon was additive. The sti­
mulation due to 10 GTP, on the other hand, was inhibited 
by 10 glucagon. The cyclic AMP level was, however, still 
higher in the presence of both GTP and glucagon than in the 
presence of glucagon alone, the results shown here with 10 
GTP are the same is seen with 5 /iM GTP.
Most of the agents whose effects on islet cyclic 
AMP levels were studied with the prelabeling method (which 
measures the relative cyclic AMP levels) were also re-
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TABLE 11
STIMULATORY EFFECT OP GLUCAGON AND GTP, PRESENT SINGLY 
OR IN COMBINATION, ON THE ACCUMULATION 
OF CYCLIC AÎ4P IN PANCREATIC ISLETS
Additive Cyclic AMP found Effect of agent
cpra/mg protein control
None (control) 19.7 (19.2;20.1) 100
Glucagon (5 ;tiM) 47.8 (43.2;52.3) 243
GTP (5;iM) 25.4 (21.8;28.9) 129
Glucagon (5 >iM)
+ GTP (5 /iM) 57.7 (57.2;58.2) 293
Glucagon (10 40.9 (43.6;38.2) 208
GTP (10 ;iM) 310,4 (300.1:320.7) 1576
Glucagon (10 >df)
+ GTP (10 fiM) 73.7 (67.1:80.2) 574
About 80 islets were incubated in 2.5 ml of Krebs- 
Ringer bicarbonate buffer containing 10 mM theophylline 
and various additives, at 37^ for 10 min, with shaking. 
Each incubation was performed in duplicate and the mean 
and the individual values (in parentheses) are presented.
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examined with the protein kinase catalytic method (which 
measures the absolute cyclic AMP levels) (Pig. 13). The 
results, presented in Table 12, confirm all the findings 
made with the prelabeling method. It is worth mentioning 
that E&TA, showing a small stimulatory effect itself, syner- 
gistically enhanced the stimulation evoked by glucagon. The 
potentiation of glucagon action by EGTA was also seen with 
the prelabeling experiments (Pig. 12), and also with adeny­
late cyclase in islet homogenates. The basal level of cy­
clic AMP in isolated islets (49.0 pmoles/mg protein, see 
footnote to Table 12), about 3-to 10-fold higher than the 
value found in many other tissues (33), was comparable to 
that reported by Turtle and Kipnis (23). Enhancement of 
intracellular cyclic AMP levels were as follows; DL-iso- 
proterenol, 491#; acetylcholine, 203#; corticotropin, 330#; 
SGTA, 41#; glucagon + EOTA, 375#; glucagon, 130#; ouabain, 
214#; prostaglandin Ê , 825#; TSH, 134#. The extracellular 
levels of cyclic AMP from the same islet incubation were 
also measured (Table 12). Some parallelism between the intra- 
and extra-cellular cyclic AMP levels as influenced by vari­
ous agents was noted.
Separation of Ovclic AMP from Other Nucleotides
The column technique (Table 13) utilized was slight­
ly different from that of Krishna et (38). Theophylline 
was separated so well from cyclic AMP that it could not in-
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Pig. 13. Standard curve for the measurement of cy­
clic AlilP with a partially purified preparation of bovine 
heart cyclic AMP dependent protein kinase. Assay conditions 
were as described under "Experimental Procedure". The ac­
tivity of the heart enzyme was proportional to cyclic AMP 
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fig.15 - Standard curve for the measurement 
of cyclic AMP with cyclic AMP dependent protein 
kinase.
Table 12. Effects of various agents on cyclic AMP levels in pancreatic 
islets. Isolation and incubation of islets and measurements of the amount of 
total cyclic AMP by the protein kinase catalytic method were as described under 
"Experimental Procedure". About 225 islets were present in each incubation tube 
of 5 ml Krebs-Ringer bicarbonate buffer containing 10 mM theophylline. Each tube 
was incubated for 10 min at 37® in a shaking water bath. Each incubation was per­
formed in duplicate and the mean is presented. Each sample from the individual 
incubations was assayed for cyclic AMP in triplicate. Values presented in the 
parentheses represent the means of such triplicate assays.
^Absolute level found in islets after 10 min incubation.
Walues corrected for cyclic AMP level found in islets before incubation 
(zero time control), which amounted to 49.0 pmoles/mg protein.




EFFECTS OF VARIOUS AGENTS ON CYCLIC AMP LEVELS IN PANCREATIC ISLETS







pmoles/mg islet pmoles/mg islet
protein protein
None
(control) 61.9 (60.0;63.7) 12.9 4.4
EL-Isoproterenol 
(0.1 mM) 125.3 (123.4;127.2) 76.3 11.2
Acetylcholine 
(0.1 mM) 88,1 (82.8;93.4) 39.1 13.3
Corticotropin 
(0.03 mM) 91.6 (89.7J98.4) 42.6 8.9
Glucagon 
(0.01 mM) 78.7 (74.9;82.4) 29.7 6.9
Thyroid-stimulating 
hormone (20 jag/ml) 79.2 (76.0;82.4) 30.2 8.9
Prostaglandin E. 
(20 Aig/ml) 118.4 (158.7:178.0) 119.4 14.1
EGTA (2 mM) 67.3 (67.3:67.3) 18.3 6.8
Glucagon (0.01 mM) + 




PURIFICATION OF CYCLIC AMP WITH AG-50WX8 COLUMNS
(0.5 X 2.5 cm)
mis of eluate collected nucleotides, etc
0.5 ml of sample loaded ATP, ADP,
+ first 2 ml of eluate Theophylline
3rd and 4th ml Cyclic AMP
0.5 ml of samples were loaded, and
eluted with water. 5*-AMP did not appear in 
the first 4 mis of collected eluate. The sepa­
ration between different nucleotides was iden­
tified by optical density (260 nÿi) and radio­
active counts of ATP and cyclic AMP.
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TABLE U





ADP...............   0.18
ATP......................... 0.14
Developed with isopropyl alcohol-water-295^ NH^OH 
(7:2:1, v/v) as solvent for 5 hours. All spots were checked 
under ultraviolet light.
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terfere with the cyclic AMP recovery examined hy optical 
density (260 mp) in adenylate cyclase assay.
In addition to the observation of values of cy­
clic AMP and 5*-AMP (77), the values of both ATP and ADP 
were examined with SilicAR TLC-7GF Mallincrodt (Table 14), 
and the results confirmed that the thin layer chromatog­
raphy technique was good enough to examine the purity of 




The pancreatic islet Isolation procedure is a mo­
dified version of that developed hy Lacy and Kostianovsky 
(20). The most significant innovation in the present pro­
cedure is the use of pilocarpine, a potent cholinomimetic 
agent. This drug has been shown to cause a complete or a 
near-complete depletion of zymogen granules from pancre­
atic acinar tissue (78). These zymogens, if present, could 
potentially be released and activated during the collagen- 
ase digestion of pancreatic tissue. The active enzymes, 
especially the proteolytic ones, could interfere with the 
isolation procedure and destroy the islet plasma membrane 
structure.
The use of a 180-mesh silk screen to retain islets 
during the washing of the collagenase-digested pancreatic 
tissue and the use of an 18-gauge needle attached to a 
siphon device for picking the islets greatly facilitate
the isolation of islets in adequate amounts for the experi* 
ments. The islets obtained by this procedure are largely
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free of acinar tissue as judged by a microscopic exami­
nation. The islet preparations, containing 1.7 - 0.1 }xg 
protein per islet, compare favorably with the value of 
about 3 protein per islet reported by others (44). 
Although the islet preparations are undoubtedly conta­
minated with small amounts of exocrine pancreatic tissue, 
the extent to which this contributed to the total adeny­
late cyclase activity may be minimal. The /6-cells, which 
are actually involved in insulin secretion, comprise 
about 60-90^ of the islet cell content (79). The res­
ponses of islet adenylate cyclase to many hormones and 
agents, might also largely represent those of ̂ -cell 
adenylate cyclase.
The advantages of the pilocarpine pretreatment of 
rats prior to preparation of the islets are clear. First, 
it permits an increased yield of islets. Second, adenylate 
cyclase in the isolated islets, perhaps with its receptors 
remaining relatively undamaged, retains its responsiveness 
to a wide variety of hormones. Author has observed with is* 
lets obtained from rats not pretreated with pilocarpine 
that adenylate cyclase activity shows little or no res­
ponse to glucagon, whereas, under the same experimental 
conditions, this hormone causes a doubling of the enzyme 
activity in islets obtained from pretreated rats. These 
results may be somewhat analogous to the f ndings of Rod- 
bell et ale made with fat cell ghosts (45)* wherein tryp­
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sin digestion of the plasma membrane causes a loss in the 
sensitivity of adenylate cyclase to hormones. It is also 
reasonable to assume that cholinergic stimulation leads 
to the discharge of insulin (and possibly glucagon) from 
the islet tissue. Acetylcholine or vagal stimulation have 
been shown to initiate insulin secretion (60, 80). Pre- 
treatment with pilocarpine could thus increase the res­
ponsiveness of islet adenylate cyclase by decreasing endo­
genous insulin or glucagon in the tissue preparation. This 
step also helped to assure that the author was not observing 
the combined effects of endogenous polypeptides and the va­
rious test substances investigated. The results of the pres­
ent study indicate that islet adenylate cyclase is respon­
sive to a great number of stimulants, perhaps reflecting a 
central role of insulin in many homeostatic mechanisms. In 
a recently published communication, Rosen et al, described 
a study concerning adenylate cyclase activity of an insulin- 
producing islet cell tumor (83). They reported that only 
glucagon and fluoride, among many substances tested, were 
capable of stimulating islet tumor adenylate cyclase. The 
agents tested and found to be ineffective were: epinephrine, 
norepinephrine, isoproterenol, arginine, glucose, prostag­
landin £̂ , ethanol, secretin, insulin and ACTH. Their re­
sults are obviously at variance with the findings. It 
should be emphasized, however, that the adenylate cyclase
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which the author studied is from normal rats which had been 
treated with pilocarpine. The purity of some hormones, such 
as pancreozymin, secretin, and TSH, used in the present 
study is rather low. The effects seen with these hormone 
preparations remain to be confirmed when pure hormones be­
come available to the author.
It has been shown (60, 61, SO) that acetylcholine 
and vagal stimulation cause an increase in insulin secre­
tion. (The author has also observed that acetylcholine el­
evates cyclic AMP levels in the intact pancreatic islets 
prepared from rats pretreated with pilocarpine.) This effect 
of acetylcholine on insulin secretion may be an indirect one, 
It may be explained, at least in part, by assuming that 
acetylcholine interacts with islet d-cells and leads to a 
release of glucagon. The glucagon, in turn, activates the 
adenylate cyclase of neighboring ̂ 8-cells, resulting in 
elevated cellular cyclic AMP levels. The effect on pancre­
atic islet cyclic AMP production by both insulin and glu­
cagon has been confirmed, but the major target cells of 
these two hormones is not absolutely clear. The finding 
that acetylcholine stimulates adenylate cyclase in the is­
let homogenates (Table 4) is quite unexpected. Nevertheless, 
it provides direct evidence supporting the contention that 
the action of acetylcholine on the organelles (and perhaps 
^-cells) may be a direct one. The ability of acetylcholine, 
like many hormones, to activate islet adenylate cyclase may
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be of particular physiological significance. It remains to 
be seen whether acetylcholine also increases cyclic GMP 
levels in islets. Several lines of recent evidence have 
suggested that cyclic GMP, but not cyclic AMP, may be in­
volved in cholinergic neurotransmission and that acetyl­
choline functions to specifically increase the tissue lev­
els of cyclic GMP (84-86).
All hormones, drugs, compounds and metabolites in 
this study were examined for their possible effects on is­
let phosphodiesterase assayed in the presence and absence 
of 10 mM theophylline. At concentrations the same as those 
employed in the adenylate cyclase studies, none of these 
hormones and agents had any significant effects on the phos­
phodiesterase activity^. Goldfine ^  |d. (70) reported that 
islet cell tumor phosphodiesterase is inhibited by tol­
butamide which has a of 3 mM. In their study, however, 
the concentrations of tolbutamide found to significantly 
inhibit phosphodiesterase were about an order of magnitude 
higher than those required to activate adenylate cyclase 
of normal islets as observed in the studies (Table 5) and 
in islet cell adenoma as reported by Levey et al. (69).
Most of the hormones and agents studied for their
^Kuo, W. N., Hodgins, D. S., Kuo, J. P. Adenylate 
cyclase in islets of Langerhans, manuscript to be submitted 
for publication.
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effects on adenylate cyclase in islet homogenates were 
also examined for their effects on the cyclic AI4P levels 
in intact islets, employing either the technique of pre­
labeling the cellular ATP pool with radioactive adenine 
(87, 88) or with the protein kinase catalytic method (53). 
Host of the results obtained with the broken cell system 
were confirmed with the intact cell experiments, except 
for NaF which was not effective in increasing cyclic AItCP 
levels in intact islets. NaP was shown earlier to be a 
potent stimulator of adenylate cyclase in fat cell ghosts 
(89) while having no effect on intact fat cells (88). Be­
cause of the three different kinds of techniques employed 
under different conditions, it was not necessary to get 
exactly the same degree of effect on pancreatic islet cyclic 
AMP production by various agents. Glucagon, isoproterenol, 
prostaglandins (S^, Sg* P^^), ACTH, secretin, acetyl­
choline, TSH, tolbutamide, EGTA, GTP, and epinephrine or 
norepinephrine in the presence of «(-adrenergic blockers 
were found to increase cyclic AMP level in rat pancreatic 
islets. The increase in intracellular cyclic AMP levels 
evoked by these agents were apparently due to their sti­
mulation of islet adenylate cyclase. In addition to the 
above mentioned agents, pancreozymin, somatotropin, GDP, 
ethanol and NaP were also found to stimulate islet adeny­
late cyclase. Many of these agents are known to have a
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physiological role or pharmacological effect in promoting 
insulin secretion. Another class of insulinogenic agents, 
such as glucose, arginine, leucine, and phenformin (an oral 
hypoglycemic drug), whose action is considered to be medi­
ated through an intracellular mechanism (62) did not in­
crease islet cyclic AMP levels. They inhibited slightly or 
exerted no effect on islet adenylate cyclase. Many of the 
hormones studied with islets are also known to act on rat 
fat cells (3 6, 81, 82). The obvious differences seen in rat 
fat cells are that prostaglandins, particularly in the pres­
ence of catecholamines and other lipolytic hormones, de­
crease cyclic AMP levels (88, 92), and that epinephrine or 
norepinephrine (in the absence or presence of o(-adrenergic 
blockers) increase cyclic AMP levels (36, 81, 82), suggest­
ing adrenergic receptors in rat fat cells are functionally 
of the ̂ -type. It is worthy mentioning that, like rat is­
lets, human fat cells were found to possess both o(-and ^- 
adrenergic receptors (93). The acetylcholine-mediated stim­
ulation of adenylate cyclase and increase of cyclic AMP 
levels in rat islets, to the authors knowledge,have not yet 
been found in other tissues. Cholinergic agents have been 
shown to stimulate the release of insulin from slices of 
rat pancreas (60, 61) and islets (40).
The author has not studied the effects of hormones 
and other agents on insulin secretion by the islet prepara­
tion, since pilocarpine pretreatment of rats may have
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depleted the Insulin stores of the ̂ -cells.
Cyclic AMP, as has been previously hypothesized, 
appears to play an important role in the secretion, and 
possibly the synthesis, of insulin (for example, see 22,
23, 40, 42, 44). The exact mechanism for the action of 
cyclic AMP, however, remains unclear. Since a complete 
correlation between adenylate cyclase activation and the 
stimulation of insulin secretion appears to be lacking, 
intracellular cyclic AMP levels alone may not be the sole 
determinants of insulin secretion. It seems at least two 
separate secretory mechanisms are involved; one being 
cyclic AMP-mediated and the other being closely associated 
with the metabolism of glucose and certain amino acids. 
Another possibility is a mechanism that requires a combi­
nation of the effects of both cyclic AMP and metabolites. 
Thus, increased intracellular cyclic AMP levels may faci­
litate insulin secretion as elicited by metabolites. How­
ever, a cyclic AMP dependent protein kinase, and a protein 
kinase modulator activity have been found in islet^. The
islet protein kinase has some catalytic properties common 
to the enzyme found in many other sources; these include 
the artificial substrate and cyclic nucleotide specificity,
2Kuo, J. P., Kuo, W. N., Hodgins, D. S., Greengard, 
P. Cyclic AMP dependent protein kinase from, islets'of'Lan­
gerhans, manuscript to be submitted for publication.
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and the metal ion requirement. No cyclic GMP dependent pro­
tein kinase activity was found. It is reasonable to assume 
that the phosphorylation catalyzed by cyclic AMP dependent 
protein kinase inside the /3-cells of islet tissue could lead 
to the decomposition of glycogen and triglyceride, the con­
formational change of histones, microtubular elements, and 
membrane proteins. Furthermore, all of above phosphoryla­
tion functions could ultimately facilitate both insulin 
biosynthesis and insulin secretion (Pig. 14). The modula­
tor inhibits or activates cyclic AMP dependent emd cyclic 
GMP dependent protein kinase under certain conditions (90, 
91), suggesting a specific role for cyclic AMP in the secre­
tion and possibly synthesis of insulin.
In addition to experiments using whole isolated is­
lets it may be quite possible to study:(a) the cyclic AMP 
system in ct-cells of pancreatic islet tissue by alloxan pre­
treatment of rats to result in the selective damage of yg- 
cells (94), (b) the secretion of insulinogenic hormones 
regulated directly or indirectly by insulin mediated through 
cyclic AMP system, (c) and the effect of gastrin, tetragas- 
trin, glucagon-like hormone, serotonin, and some other an­
alogs of cyclic AMP (tubercidin 3*, 5'-monophosphate, 3*- 
methylene cyclic phosphonate analog, 5*-methylene cyclic 
phosphonate analog, and dibutyryl analog of cyclic AMP) on 
pancreatic islet cyclic AMP production.
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Pig. 14 - Possible mechanism of cyclic AMP 




An Improved method for the Isolation of rat pancre­
atic islets possessing adenylate cyclase responsive to var­
ious hormones is described. The key step in this method, 
which yielded up to 500 islets per pancreas, involved pre­
treatment of rats with pilocarpine. This allowed depletion 
of zymogens from the exocrine pancreatic tissue and thus 
minimized the destruction of islet membranal structure which 
could otherwise occur during the collagenase digestion of 
the tissue.
The adenylate cyclase activity in the islet homoge­
nates was assayed in the presence of a variety of hormones 
and other agents. With the exception of some insulinogenic 
metabolites, such as goucose, arginine and leucine, all hor­
mones previously demonstrated by others to stimulate insulin 
secretion were found to augment the synthesis of cyclic AMP 
by islet adenylate cyclase. These agents include glucagon, 
adrenocorticotropic hormone, secretin, pancreozymin, various 
prostaglandins, and^-adrenergic agents. Acetylcholine, thy­
rotropin, somatotropin, ethanol, EGTA, GTP, GDP, and NaF
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also stinnilated cyclic AMP production, but their Insullno- 
genlc action has not been clearly demonstrated. Of the two 
hypoglycemic drugs studied, tolbutamide was found to stimu­
late the cyclase activity whereas phenformin was without 
effect. Insulin Inhibited the Islet adenylate cyclase acti­
vity, suggesting a possible feed-back mechanism Involved. 
None of these agents had any effect on the Islet phospho­
diesterase activity.
Regulation by various agents of cyclic AMP levels 
In Intact Islets of rat pancreas was studied, employing 
either the technique of prelabeling the cellular ATP pool 
or the protein kinase catalytic method. The results obtain­
ed with the Intact cell system confirmed most of the find­
ings made with the broken cell system, clearly suggesting 
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